Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)

The severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV-2) poses a threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID-19), characterized by an acute and often severe form of pneumonia, has been declared a pandemic. This has led to a boom in biom...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Oncol
Egile Nagusiak: Vivarelli, Silvia, Falzone, Luca, Torino, Francesco, Scandurra, Giuseppa, Russo, Giulia, Bordonaro, Roberto, Pappalardo, Francesco, Spandidos, Demetrios A., Raciti, Giuseppina, Libra, Massimo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2020
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864014/
https://ncbi.nlm.nih.gov/pubmed/33491759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5159
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak